1. Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications

   • Reinou S. Groen
   • A. Wolter J. Oosterhuis
   • James E. Boers

   Pre-clinical Study 13 January 2007 Pages: 1 - 5

2. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer

   • Y. S. Lau
   • L. Danks
   • N. A. Athanasou

   PRECLINICAL STUDY 07 December 2006 Pages: 7 - 16

   

3. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer

   • Hope Rugo
   • Emma Shtivelman
   • Debu Tripathy

   Critical Trial 17 November 2006 Pages: 17 - 28

   

4. Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells

   • John Yoonkeun Jun
   • James W. Griffith
   • Andrea Manni

   Clinical Study 02 December 2006 Pages: 29 - 36

   

5. Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis

   • S. Ciatto
   • N. Houssami
   • M. Rosselli Del Turco

   Epidemiology 18 November 2006 Pages: 37 - 43

6. Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors

   • Page E. Abrahamson
   • Shelley S. Tworoger
   • Anne McTiernan

   Epidemiology 01 November 2006 Pages: 45 - 54

7. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival

   • Aesun Shin
   • Zefang Ren
   • Wei Zheng

   Epidemiology 26 October 2006 Pages: 55 - 61

   

8. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer

   • N. van den Broek
   • M. J. C. van der Sangen
   • A. C. Voogd

   EPIDEMILOGY 18 November 2006 Pages: 63 - 68

   

9. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study

   • Jane C. Figueiredo
   • Marguerite Ennis
   • Pamela J. Goodwin

   Clinical Epidemiology 18 November 2006 Pages: 69 - 80

   

10. Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature

    • Alberto Luini
    • Giovanna Gatti
    • Giuseppe Viale

    Original Paper 18 November 2006 Pages: 81 - 85

    

11. Serial 2-[¹⁸F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)

    • Jennifer M. Specht
    • Stephen L. Tam
    • David A. Mankoff

    Original Paper 01 February 2007 Pages: 87 - 94

    

12. Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro

    • E. Bucciarelli
    • A. Sidoni
    • A. Bellahcène

    Original Paper 30 November 2006 Pages: 95 - 104

    

13. Mid-region parathyroid hormone-related protein (PTHrP) binds chromatin of MDA-MB231 breast cancer cells and isolated oligonucleotides “in vitro”

    • Rosalia Sirchia
    • Marcella Priulla
    • Claudio Luparello

    Original Paper 24 November 2006 Pages: 105 - 116